United Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for UNITED THERAP, and what generic alternatives to UNITED THERAP drugs are available?
UNITED THERAP has five approved drugs.
There are twenty-nine US patents protecting UNITED THERAP drugs. There is one tentative approval on UNITED THERAP drugs.
There are two hundred and eight patent family members on UNITED THERAP drugs in twenty-two countries.
Summary for United Therap
| International Patents: | 208 |
| US Patents: | 29 |
| Tradenames: | 4 |
| Ingredients: | 2 |
| NDAs: | 5 |
| Patent Litigation for United Therap: | See patent lawsuits for United Therap |
| PTAB Cases with United Therap as patent owner: | See PTAB cases with United Therap as patent owner |
Drugs and US Patents for United Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Therap | REMODULIN | treprostinil | SOLUTION;INTRAVENOUS, SUBCUTANEOUS | 208276-003 | Jul 30, 2018 | DISCN | No | No | 9,604,901 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-002 | Dec 20, 2013 | RX | Yes | No | 9,593,066 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-004 | Dec 20, 2013 | RX | Yes | No | 7,544,713 | ⤷ Sign Up | ⤷ Sign Up | ||||
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-004 | Dec 20, 2013 | RX | Yes | No | 9,593,066 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-005 | Oct 7, 2016 | RX | Yes | No | 8,410,169 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for United Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| United Therap | REMODULIN | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 021272-002 | May 21, 2002 | 6,765,117 | ⤷ Sign Up |
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-001 | Dec 20, 2013 | 6,765,117 | ⤷ Sign Up |
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-002 | Dec 20, 2013 | 9,050,311 | ⤷ Sign Up |
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-004 | Dec 20, 2013 | 9,422,223 | ⤷ Sign Up |
| United Therap | TYVASO | treprostinil | SOLUTION;INHALATION | 022387-001 | Jul 30, 2009 | 6,765,117 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for UNITED THERAP drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 10 mg/mL, 20 mL vial | ➤ Subscribe | 2011-12-02 |
| ➤ Subscribe | Inhalation Solution | 0.6 mg/mL, 2.9 mL ampules | ➤ Subscribe | 2015-04-13 |
| ➤ Subscribe | Extended-release Tablets | 0.25 mg and 1 mg | ➤ Subscribe | 2016-05-19 |
| ➤ Subscribe | Injection | 1 mg/mL, 2.5 mg/mL, and 5 mg/mL, 20 mL vial | ➤ Subscribe | 2012-12-07 |
| ➤ Subscribe | Extended-release Tablets | 2.5 mg | ➤ Subscribe | 2015-12-24 |
International Patents for United Therap Drugs
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
